Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease: a post hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2020 - academic.oup.com
Background The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …
被引用次数：39 相关文章

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2020 - academic.oup.com
Background The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …

Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2020 - cris.bgu.ac.il
Background: The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2020 - go.gale.com
Background: The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …
[PDF] academia.edu

[PDF][PDF] Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post …

M Matar, R Shamir, D Turner, E Broide, B Weiss… - Inflamm Bowel …, 2020 - academia.edu
Background: The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2020 - europepmc.org
Background The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc …

M Matar, R Shamir, D Turner, E Broide, B Weiss… - 2020 - pubmed.ncbi.nlm.nih.gov
Background The PAILOT trial was a randomized controlled trial aimed to evaluate proactive
vs reactive therapeutic drug monitoring in children with Crohn's disease (CD) treated with …

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc …

M Matar, R Shamir, D Turner, E Broide… - Inflammatory Bowel …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The PAILOT trial was a randomized controlled trial aimed to evaluate proactive vs reactive …